SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,800,000 | $1,350,180 | 0.33% |
| Deuterium Capital Management, LLC | 11,000 | $8,800 | 0.02% |
| Duquesne Family Office | 100,000 | $80 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $84,686 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 14,000 | $11,200 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 10,876 | $8,701 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 90,774 | $72,619 | 0.00% |
| WELLS FARGO & COMPANY/MN | 132 | $106 | 0.00% |
| NORTHERN TRUST CORP | 26,049 | $20,839 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |